Our economic performance can be measured through our investment in innovative research and development, where we are looking for new and better treatments for:
- alzheimer's disease
- psychiatric disorders
- rheumatoid arthritis
- solid organ transplant rejection
It can be measured through our history of successful efforts and partnerships to develop and deliver important new medicines to people who need them. Finally, our performance can be measured through our efforts to help expand people’s access to quality medicines and health care, through worldwide public/private partnerships. Examples include the five areas of focus of The Bristol-Myers Squibb Foundation: HIV/AIDS in Africa (our pioneering $150 million HIV/AIDS SECURE THE FUTURE®), mental illness and type 2 diabetes in the United States, hepatitis in Asia and cancer in Eastern Europe; as well as our patient assistance programs.
For more detailed information about our financial goals, our performance and additional relevant information, see our company’s Investors site, our Annual Report and our Foundation Bristol-Myers Squibb Report.